Total Payments
$13,850
2024 Payments
$4,300
Companies
24
Transactions
151
Medicare Patients
1,648
Medicare Billing
$123,469
Payment Breakdown by Category
Travel$7,992 (57.7%)
Food & Beverage$5,857 (42.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $7,992 | 24 | 57.7% |
| Food and Beverage | $5,857 | 127 | 42.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Inari Medical, Inc. | $2,588 | 9 | $0 (2024) |
| Penumbra, Inc. | $2,104 | 9 | $0 (2023) |
| Medtronic, Inc. | $2,090 | 30 | $0 (2024) |
| Abbott Laboratories | $2,051 | 14 | $0 (2023) |
| ABIOMED | $1,988 | 20 | $0 (2024) |
| Philips North America LLC | $1,502 | 8 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $286.24 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $233.67 | 16 | $0 (2024) |
| ShockWave Medical, Inc | $125.81 | 3 | $0 (2024) |
| Boston Scientific Corporation | $109.72 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,300 | 75 | ABIOMED ($1,934) |
| 2023 | $6,219 | 53 | Abbott Laboratories ($2,051) |
| 2022 | $3,330 | 23 | Medtronic, Inc. ($1,648) |
All Payment Transactions
151 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Medtronic, Inc. | NANOCROSS ELITE (Device) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Percutaneous Transluminal Angioplasty (PTA) Balloons | ||||||
| 12/17/2024 | Medtronic, Inc. | ABRE (Device) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Stents | ||||||
| 12/17/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $4.06 | General |
| Category: Renal Denervation System | ||||||
| 12/12/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE 6/7F VCS (Device) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: DEVICES | ||||||
| 12/07/2024 | ABIOMED | Impella (Device) | Travel and Lodging | Cash or cash equivalent | $493.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/07/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $156.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/07/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $59.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2024 | ABIOMED | Impella (Device) | Travel and Lodging | Cash or cash equivalent | $413.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $153.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $49.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $5.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $147.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | Medtronic, Inc. | ABRE (Device) | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: Stents | ||||||
| 11/27/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: Renal Denervation System | ||||||
| 11/26/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Cardiology | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $17.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Renal Denervation System | ||||||
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: DIABETES | ||||||
| 11/08/2024 | Medtronic, Inc. | NANOCROSS ELITE (Device) | Food and Beverage | In-kind items and services | $8.20 | General |
| Category: Percutaneous Transluminal Angioplasty (PTA) Balloons | ||||||
| 11/06/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Cardiology | ||||||
| 10/23/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $89.16 | General |
| Category: Lithoplasty | ||||||
| 10/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: DIABETES | ||||||
| 09/23/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: Renal Denervation System | ||||||
| 09/11/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Renal Denervation System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,357 | 1,598 | $319,431 | $101,482 |
| 2022 | 12 | 291 | 325 | $68,256 | $21,987 |
Total Patients
1,648
Total Services
1,923
Medicare Billing
$123,469
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 129 | 232 | $57,197 | $21,568 | 37.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 40 | 84 | $50,316 | $13,605 | 27.0% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 59 | 61 | $38,552 | $12,490 | 32.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 90 | 90 | $29,085 | $10,533 | 36.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 50 | 51 | $22,389 | $6,660 | 29.7% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 14 | 15 | $18,990 | $6,170 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 86 | $14,519 | $5,390 | 37.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 45 | 45 | $13,590 | $4,124 | 30.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 42 | 56 | $9,072 | $3,390 | 37.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 21 | 21 | $7,910 | $2,870 | 36.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 41 | 41 | $7,275 | $2,216 | 30.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 276 | 288 | $6,336 | $1,790 | 28.3% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 23 | 24 | $4,896 | $1,689 | 34.5% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 45 | 45 | $3,424 | $1,204 | 35.2% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 22 | 25 | $6,475 | $1,201 | 18.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 98 | 103 | $4,532 | $1,067 | 23.5% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 84 | 90 | $8,257 | $872.20 | 10.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,311 | $825.33 | 35.7% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 41 | 42 | $2,282 | $753.66 | 33.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 12 | $2,061 | $734.02 | 35.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 13 | 13 | $3,571 | $679.25 | 19.0% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 14 | 14 | $2,273 | $553.03 | 24.3% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 34 | 35 | $1,995 | $487.73 | 24.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 36 | 36 | $1,368 | $352.44 | 25.8% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 46 | 78 | $755.82 | $257.25 | 34.0% |
About Dr. Abdul Khan, M.D
Dr. Abdul Khan, M.D is a Interventional Cardiology healthcare provider based in Las Cruces, New Mexico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2015. The National Provider Identifier (NPI) number assigned to this provider is 1528449576.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abdul Khan, M.D has received a total of $13,850 in payments from pharmaceutical and medical device companies, with $4,300 received in 2024. These payments were reported across 151 transactions from 24 companies. The most common payment nature is "Travel and Lodging" ($7,992).
As a Medicare-enrolled provider, Khan has provided services to 1,648 Medicare beneficiaries, totaling 1,923 services with total Medicare billing of $123,469. Data is available for 2 years (2022–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location Las Cruces, NM
- Active Since 06/16/2015
- Last Updated 12/08/2022
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1528449576
Products in Payments
- FLOWTRIEVER CATHETER, S (Device) $2,147
- Impella (Device) $1,988
- Indigo System (Device) $1,974
- SUPERA (Device) $1,733
- RESOLUTE ONYX (Device) $1,648
- (9520) IGT Devices Undivided (Device) $1,478
- CT THROMBECTOMY SYSTEM KIT (Device) $441.30
- DIAMONDBACK CORONARY (Device) $186.49
- LEQVIO (Drug) $174.73
- HAWKONE (Device) $163.99
- Optimizer (Device) $146.01
- OPTIMIZER (Device) $140.23
- XACT (Device) $131.67
- Penumbra System (Device) $129.53
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $125.81
- JARDIANCE (Drug) $100.79
- ABRE (Device) $91.99
- Barostim Neo System (Device) $76.34
- FUROSCIX (Drug) $74.53
- SYMPLICITY G3 (Device) $71.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.